Stockscreener 앱 받기
9.249
2.44%
0.219
전일 마감가:
$9.03
열려 있는:
$9.24
하루 거래량:
176.04K
Relative Volume:
0.27
시가총액:
$467.76M
수익:
$89.04M
순이익/손실:
$-241.08M
주가수익비율:
-1.7584
EPS:
-5.26
순현금흐름:
$-194.72M
1주 성능:
-2.53%
1개월 성능:
+6.20%
6개월 성능:
+18.59%
1년 성능:
-26.18%
1일 변동 폭
$9.17
$9.4825
1주일 범위
$8.82
$9.6115
52주 변동 폭
$5.035
$13.15
Regenxbio Inc Stock (RGNX) Company Profile
명칭
Regenxbio Inc
전화
240-552-8181
주소
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD
RGNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RGNX
Regenxbio Inc
|
9.26 | 456.14M | 89.04M | -241.08M | -194.72M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.88 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.04 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.52 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
730.78 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.45 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Regenxbio Inc Stock (RGNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-07 | 재개 | Raymond James | Outperform |
| 2024-11-15 | 재개 | Morgan Stanley | Overweight |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-06-07 | 개시 | Goldman | Buy |
| 2024-03-11 | 개시 | H.C. Wainwright | Buy |
| 2024-03-08 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-03-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-21 | 재개 | Raymond James | Outperform |
| 2023-11-01 | 개시 | Stifel | Buy |
| 2023-06-02 | 개시 | Robert W. Baird | Outperform |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-12-15 | 개시 | Wedbush | Neutral |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-01-06 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-08-20 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2019-06-18 | 재확인 | Chardan Capital Markets | Buy |
| 2019-06-14 | 재개 | Raymond James | Outperform |
| 2019-06-05 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-25 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-02-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-12-17 | 재확인 | Chardan Capital Markets | Buy |
| 2018-11-08 | 재확인 | BofA/Merrill | Neutral |
| 2018-08-08 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-23 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-07-10 | 재확인 | Chardan Capital Markets | Buy |
| 2018-05-09 | 재확인 | Barclays | Overweight |
| 2018-04-09 | 재확인 | Chardan Capital Markets | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-02-13 | 개시 | Mizuho | Neutral |
| 2017-11-09 | 재개 | Morgan Stanley | Overweight |
모두보기
Regenxbio Inc 주식(RGNX)의 최신 뉴스
Q3 Earnings Forecast for REGENXBIO Issued By Leerink Partnrs - MarketBeat
REGENXBIO Inc. (NASDAQ:RGNX) Receives $28.38 Consensus Price Target from Analysts - MarketBeat
Is REGENXBIO Inc impacted by rising ratesJuly 2025 PreEarnings & Weekly High Conviction Trade Ideas - خودرو بانک
Aug Chart Watch: Is REGENXBIO Inc stock undervalued right nowRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
MACD Signal: Is REGENXBIO Inc stock undervalued right nowIPO Watch & Precise Swing Trade Entry Alerts - خودرو بانک
Market Rankings: How is REGENXBIO Inc managing supply chain issuesWeekly Trend Recap & Capital Efficient Trading Techniques - خودرو بانک
US Market Wrap: Whats the beta of REGENXBIO Inc stockQuarterly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Swing Trade: Can REGENXBIO Inc. maintain sales growth2025 Key Lessons & Real-Time Chart Pattern Alerts - خودرو بانک
Profit Review: Is REGENXBIO Inc impacted by rising ratesEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Investment Review: Is UMH Properties Inc a defensive stockExit Point & Daily Volume Surge Signals - خودرو بانک
Published on: 2025-09-16 04:03:08 - خودرو بانک
Smart Money: Is REGENXBIO Inc stock showing strong momentumJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Aug Macro: Is REGENXBIO Inc stock a good dividend stockEarnings Recap Summary & Free Verified High Yield Trade Plans - خودرو بانک
Exome Asset Management LLC Takes $2.90 Million Position in REGENXBIO Inc. $RGNX - MarketBeat
REGENXBIO (NASDAQ:RGNX) Earns Buy Rating from Chardan Capital - MarketBeat
REGENXBIO (NASDAQ:RGNX) Earns "Buy" Rating from HC Wainwright - MarketBeat
Insider Sell: Curran Simpson Sells Shares of Regenxbio Inc (RGNX) - GuruFocus
Ultragenyx Makes Bid for Dimension TherapeuticsBiotech Movers - TheStreet
Ieq Capital LLC Takes Position in REGENXBIO Inc. $RGNX - MarketBeat
Invesco Ltd. Purchases 27,341 Shares of REGENXBIO Inc. $RGNX - MarketBeat
Patients Treated With REGENXBIO's MPS II Gene Therapy RGX-121 Sustain 82% Median Reduction in CSF HS D2S6 Levels Through 1 Year - CGTLive®
Can REGENXBIO Inc. maintain sales growthInsider Buying & Fast Exit Strategy with Risk Control - Lancaster City Council
Is REGENXBIO Inc. in a long term uptrendTrade Volume Summary & AI Forecast Swing Trade Picks - Lancaster City Council
Regenxbio says FDA extends review date for Hunter syndrome drug - MSN
Regenxbio: Poised For Breakthrough With RGX-121 Gene Therapy In Hunter Syndrome - Seeking Alpha
PDT Partners LLC Buys 39,501 Shares of REGENXBIO Inc. $RGNX - MarketBeat
Regenxbio at Morgan Stanley Conference: Gene Therapy Progress and Financial Strength - Investing.com Canada
Moving Average Crossover Confirms Uptrend in REGENXBIO Inc.July 2025 Summary & Weekly High Conviction Ideas - beatles.ru
Regenxbio stock rating reiterated at Buy by H.C. Wainwright on positive trial data - Investing.com
Pattern Scan Adds REGENXBIO Inc. to WatchlistJuly 2025 Chart Watch & Fast Gaining Stock Strategy Reports - beatles.ru
Trade Report: What is REGENXBIO Inc. s debt to equity ratio2025 Top Gainers & Weekly High Return Forecasts - 뉴스영
124,700 Shares in REGENXBIO Inc. $RGNX Bought by Nuveen LLC - MarketBeat
ADAR1 Capital Management LLC Acquires 162,423 Shares of REGENXBIO Inc. $RGNX - MarketBeat
RegenXBio (RGNX) Receives a Buy from Raymond James - The Globe and Mail
What recovery options are there for REGENXBIO Inc.2025 Risk Factors & Expert Approved Momentum Ideas - Newser
REGENXBIO Inc. recovery potential after sell offAnalyst Downgrade & Safe Entry Zone Identification - Newser
Regenxbio: Remains A "Buy Rating" Despite BLA Review Delay Of RGX-121 For Hunter Syndrome (NASDAQ:RGNX) - Seeking Alpha
Can REGENXBIO Inc. expand into new markets2025 Earnings Surprises & Advanced Technical Signal Analysis - خودرو بانک
Top chart patterns to watch in REGENXBIO Inc.Weekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
Is REGENXBIO Inc.’s ROIC above industry averageTreasury Yields & Real-Time Stock Movement Alerts - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target - Investing.com Australia
REGENXBIO reports positive one-year data for MPS II gene therapy - Investing.com Nigeria
Should value investors consider REGENXBIO Inc.2025 Stock Rankings & Daily Stock Trend Reports - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target By Investing.com - Investing.com South Africa
Can REGENXBIO Inc. expand its profit marginsWeekly Risk Report & Free Reliable Trade Execution Plans - خودرو بانک
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data - Investing.com Nigeria
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data By Investing.com - Investing.com South Africa
Will REGENXBIO Inc. bounce back from current supportQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Regenxbio Inc (RGNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.17%
0.20%
자본화:
|
볼륨(24시간):